(SNDA) Sonida Senior Living - Overview
Sector: Healthcare | Industry: Medical Care Facilities | Exchange: NYSE (USA) | Market Cap: 1.736m USD | Total Return: 50.3% in 12m
Avg Turnover: 26.1M
Qual. Beats: -3
Rev. Trend: 99.5%
Warnings
High Debt/EBITDA (307.5) with thin interest coverage (-1.4)
High Debt while negative Cash Flow
Interest Coverage Ratio -1.4 is critical
Altman Z'' -1.67 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Sonida Senior Living, Inc. (SNDA), formerly Capital Senior Living Corporation, operates a portfolio of senior housing communities across the United States. The company provides a continuum of care that includes independent living, assisted living, and specialized memory care services. Its business model focuses on recurring revenue through monthly resident fees that cover housing, hospitality services, and tiered levels of clinical assistance.
The company’s service offerings range from basic housekeeping and meal programs to intensive support for activities of daily living (ADLs) and dementia care. To supplement its core operations, Sonida facilitates access to third-party medical providers for rehabilitation and therapy services. The senior housing sector is currently driven by demographic shifts, specifically the aging Baby Boomer population, which increases demand for high-acuity care settings.
For a deeper look into the companys financial health and valuation metrics, consider reviewing the latest data on ValueRay. Founded in 1990 and headquartered in Dallas, Texas, Sonida remains a specialized operator in the healthcare real estate and services market.
- Occupancy growth and rate increases drive organic revenue expansion
- Operating leverage improves margins as labor and insurance costs stabilize
- Strategic acquisitions and capital expenditures accelerate portfolio growth
- Debt refinancing and deleveraging strengthen balance sheet and reduce interest expense
| Net Income: -99.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 0.83 > 1.0 |
| NWC/Revenue: -45.40% < 20% (prev -5.28%; Δ -40.12% < -1%) |
| CFO/TA -0.01 > 3% & CFO -15.3m > Net Income -99.5m |
| Current Ratio: 0.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.1m) vs 12m ago 0.33% < -2% |
| Gross Margin: -29.88% > 18% (prev 0.90%; Δ -3.08k% > 0.5%) |
| Asset Turnover: 23.86% > 50% (prev 39.88%; Δ -16.02% > 0%) |
| Interest Coverage Ratio: -1.37 > 6 (EBITDA TTM 5.00m / Interest Expense TTM 42.4m) |
| A: -0.07 (Total Current Assets 146.7m - Total Current Liabilities 333.7m) / Total Assets 2.63b |
| B: -0.20 (Retained Earnings -532.2m / Total Assets 2.63b) |
| C: -0.03 (EBIT TTM -58.0m / Avg Total Assets 1.73b) |
| D: -0.31 (Book Value of Equity -531.8m / Total Liabilities 1.74b) |
| Altman-Z'' = -1.67 = D |
| DSRI: 1.26 (Receivables 26.0m/16.5m, Revenue 411.9m/328.8m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.48 (AQ_t 0.11 / AQ_t-1 0.04) |
| SGI: 1.25 (Revenue 411.9m / 328.8m) |
| TATA: -0.03 (NI -99.5m - CFO -15.3m) / TA 2.63b) |
| Beneish M = -1.78 (Cap -4..+1) = B |
As of May 27, 2026, the stock is trading at USD 37.52 with a total of 696,782 shares traded.
Over the past week, the price has changed by +1.57%,
over one month by +3.08%,
over three months by +4.86% and
over the past year by +50.26%.
Sonida Senior Living has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold SNDA.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 38.8 | 3.3% |
P/E Forward = 22.1239
P/S = 4.727
P/B = 1.96
P/EG = 2.0444
Revenue TTM = 411.9m USD
EBIT TTM = -58.0m USD
EBITDA TTM = 5.00m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 218.7m USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter) + Leases 566k
Net Debt = 1.54b USD (calculated: Debt 1.62b - CCE 84.3m)
Enterprise Value = 3.28b USD (1.74b + Debt 1.62b - CCE 84.3m)
Interest Coverage Ratio = -1.37 (Ebit TTM -58.0m / Interest Expense TTM 42.4m)
EV/FCF = -69.61x (Enterprise Value 3.28b / FCF TTM -47.1m)
FCF Yield = -1.44% (FCF TTM -47.1m / Enterprise Value 3.28b)
FCF Margin = -11.42% (FCF TTM -47.1m / Revenue TTM 411.9m)
Net Margin = -24.15% (Net Income TTM -99.5m / Revenue TTM 411.9m)
Gross Margin = -29.88% ((Revenue TTM 411.9m - Cost of Revenue TTM 534.9m) / Revenue TTM)
Gross Margin QoQ = -10.09% (prev -156.5%)
Tobins Q-Ratio = 1.25 (Enterprise Value 3.28b / Total Assets 2.63b)
Interest Expense / Debt = 2.61% (Interest Expense 42.4m / Debt 1.62b)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.9m (EBIT -58.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.44 (Total Current Assets 146.7m / Total Current Liabilities 333.7m)
Debt / Equity = 1.83 (Debt 1.62b / totalStockholderEquity, last quarter 884.9m)
Debt / EBITDA = 307.5 (Net Debt 1.54b / EBITDA 5.00m)
Debt / FCF = -32.70 (negative FCF - burning cash) (Net Debt 1.54b / FCF TTM -47.1m)
Total Stockholder Equity = 281.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.76% (Net Income -99.5m / Total Assets 2.63b)
RoE = -12.23% (Net Income TTM -99.5m / Total Stockholder Equity 813.5m)
RoCE = -2.62% (EBIT -58.0m / Capital Employed (Equity 813.5m + L.T.Debt 1.40b))
RoIC = -1.83% (negative operating profit) (NOPAT -45.9m / Invested Capital 2.51b)
WACC = 5.47% (E(1.74b)/V(3.36b) * Re(8.65%) + D(1.62b)/V(3.36b) * Rd(2.61%) * (1-Tc(0.21)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.39 | Cagr: 49.46%
[DCF] Fair Price = unknown (Cash Flow -47.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.55 | # QB: -3
Revenue Correlation: 99.53 | Revenue CAGR: 26.02% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.81 | Chg30d=+5.45% | Revisions=N/A | Analysts=3
EPS next Quarter (2026-09-30): EPS=-0.65 | Chg30d=-25.63% | Revisions=N/A | Analysts=3
EPS current Year (2026-12-31): EPS=-3.90 | Chg30d=-132.34% | Revisions=N/A | GrowthEPS=+7.5% | GrowthRev=+98.2%
EPS next Year (2027-12-31): EPS=-1.42 | Chg30d=-53.99% | Revisions=N/A | GrowthEPS=+63.7% | GrowthRev=-18.1%